CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Quidel's ROI per quarter

Return on Investment, Quarterly Results, Trends, Rankings, Statistics


Return On Investment (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Investment Change 108.34 % 95.45 % 40.67 % 7.61 % -
Y / Y Net Income Change 342.59 % 1435.07 % 1335.44 % 5226.93 % 61.96 %
Investment (TTM) in Millions 1,730 1,534 1,041 790 831
Return On Investment (TTM) 74.42 % 77.24 % 43.03 % 19.67 % 11.43 %
QDEL's Overall Ranking # 72 # 64 # 132 # 377 # 817
Seq. Investment Change 12.79 % 47.31 % 31.84 % -4.89 % 5.81 %
Seq. Net Income Change -62.12 % 102.41 % 243.33 % 68.13 % 31.38 %
Net Income (TTM) in Millions 948 810 371 155 88


Roi Comment
Quidel Corporation achieved return on average invested assets of 74.42 % in I. Quarter, above company average return on investment.

ROI decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 17 other companies have achieved higher return on investment. While Return on investment total ranking has deteriorated compare to previous quarter from 64 to 72.

Definition and Formula of Return on Investment
Return On Investment QDEL's Ranking
Within: No.
Industry # 4
Sector # 18
Overall # 72

Return On Investment Statistics
High Average Low
73.44 %
18.13 %
0.55 %
(Dec 31 2020)   (Sep. 30, 2015)





Financial Statements
Quidel's first quarter Investments $ 1,730 Millions QDEL's Balance sheet
Quidel's first quarter Income $ 178 Millions Quarterly QDEL's Income Statement
QDEL's Income by Division See QDEL's Income by Division


QDEL Annual Return On Investment (Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
Total Investments in Millions 1,534 785 503 630 355
Y / Y Investment Growth 95.45 % 55.91 % -20.05 % 77.57 % -5.6 %
Net Income in Millions 810 73 74 -8 -14
Y / Y Net Income Growth 1011.18 % -1.7 % - - -
Annual Return On Investment 52.81 % 9.29 % 14.73 % - -


Annual Roi Comment
In the fiscal year 2020 ROI improved to 52.81 % compare to previous year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Drugs Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
QDEL's Roi Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for QDEL's Competitors
Roi for Quidel's Suppliers
Return On Investment for QDEL's Customers

Other Ratios
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Statistics
QDEL's Annual Roi QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2021, within Healthcare Sector ROI
Agios Pharmaceuticals Inc   129.54 %
Ovid Therapeutics Inc   121.25 %
Fulgent Genetics Inc   100.97 %
Alpha Pro Tech Ltd  99.81 %
Chemomab Therapeutics Ltd   92.62 %
Molecular Templates Inc   89.58 %
Co diagnostics Inc   88.62 %
Mettler Toledo International Inc  87.85 %
Community Health Systems Inc   87.73 %
Idexx Laboratories Inc  82.71 %
Health Discovery Corp  70.40 %
Quidel Corporation  70.38 %
Retractable Technologies Inc  69.70 %
Antares Pharma Inc   64.05 %
Fitlife Brands Inc   61.87 %
Semler Scientific inc   61.69 %
Fortium Holdings Corp   57.84 %
Xeris Pharmaceuticals Inc   56.11 %
Hologic Inc  54.20 %
Integrated Biopharma Inc  54.09 %
Siga Technologies Inc  51.48 %
Innoviva inc   50.95 %
Hca Healthcare Inc   50.36 %
National Research Corporation  49.08 %
Infusystem Holdings Inc  47.40 %
Catalyst Pharmaceuticals Inc   46.58 %
Sage Therapeutics Inc   45.89 %
Integrity Applications Inc   40.76 %
Sunlink Health Systems Inc  39.87 %
Bionexus Gene Lab Corp  37.98 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PFPT's Profile

Stock Price

PFPT's Financials

Business Description

Fundamentals

Charts & Quotes

PFPT's News

Suppliers

PFPT's Competitors

Customers & Markets

Economic Indicators

PFPT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071